Dual-target drug may lead to new treatment approach for breast cancer patients

Updated on: April 01,2025 0

Dual-target drug may lead to new treatment approach for breast cancer patients

Updated on:April 01,2025 0

Cancer risk declines in old age: New research helps explain why

by Ian Demsky,Memorial Sloan Kettering Cancer CenterAged AT2 cells exhibit reduced cell-intrinsic potential for regeneration and tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s415

Updated on: December 21,2024 0

Cancer risk declines in old age: New research helps explain why

by Ian Demsky,Memorial Sloan Kettering Cancer CenterAged AT2 cells exhibit reduced cell-intrinsic potential for regeneration and tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s415

Updated on:December 21,2024 0

Scientists develop scans that light up aggressive cancer tumors for better treatment

byKing's College London[18F]FSPG PET can differentiate NRF2-high from NRF2-low tumors when grown orthotopically in the lungs of mice. Credit:Nature Communications(2024) DOI: 10.1

Updated on: January 22,2025 0

Scientists develop scans that light up aggressive cancer tumors for better treatment

byKing's College London[18F]FSPG PET can differentiate NRF2-high from NRF2-low tumors when grown orthotopically in the lungs of mice. Credit:Nature Communications(2024) DOI: 10.1

Updated on:January 22,2025 0

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Updated on: January 22,2025 0

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Updated on:January 22,2025 0

When blood cancer starts to spread, tumor cells diversify and affect immune response

Updated on: April 01,2025 0

When blood cancer starts to spread, tumor cells diversify and affect immune response

Updated on:April 01,2025 0

Annual report reveals more cancers are being treated with personalized therapies before surgery

byAmerican College of SurgeonsWhat to know about breast cancer according to the National Cancer Database. Credit: American College of SurgeonsBreast, bladder, and pancreatic cancers are increasi

Updated on: December 21,2024 0

Annual report reveals more cancers are being treated with personalized therapies before surgery

byAmerican College of SurgeonsWhat to know about breast cancer according to the National Cancer Database. Credit: American College of SurgeonsBreast, bladder, and pancreatic cancers are increasi

Updated on:December 21,2024 0

Clinical trial demonstrates efficacy and tolerability of new drug for hemophilia patients

bySaarland UniversityCredit: CC0 Public DomainFor people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally cut their finger while

Updated on: December 18,2024 0

Clinical trial demonstrates efficacy and tolerability of new drug for hemophilia patients

bySaarland UniversityCredit: CC0 Public DomainFor people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally cut their finger while

Updated on:December 18,2024 0

Anticancer drugs could make immunotherapies more effective

byWeill Cornell Medical CollegePretreatment with EZH2 inhibitor (top right) leads to higher recruitment of CAR-T cells (red) into the lymph node tumor compared with control (top left). Pretreatm

Updated on: December 21,2024 0

Anticancer drugs could make immunotherapies more effective

byWeill Cornell Medical CollegePretreatment with EZH2 inhibitor (top right) leads to higher recruitment of CAR-T cells (red) into the lymph node tumor compared with control (top left). Pretreatm

Updated on:December 21,2024 0

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Updated on: January 22,2025 0

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Updated on:January 22,2025 0

Prevention and screening outpace treatment advances for averting death from five cancer types, study reveals

byNational Cancer InstituteCredit: Pixabay/CC0 Public DomainImprovements in cancer prevention and screening have averted more deaths from five cancer types combined over the past 45 years than t

Updated on: December 20,2024 0

Prevention and screening outpace treatment advances for averting death from five cancer types, study reveals

byNational Cancer InstituteCredit: Pixabay/CC0 Public DomainImprovements in cancer prevention and screening have averted more deaths from five cancer types combined over the past 45 years than t

Updated on:December 20,2024 0

Survival rates for incurable larynx cancer investigated for first time

byNewcastle UniversityKaplan Meier Survival Curves with associated estimated survival rates for entire cohort. Credit:Clinical Otolaryngology(2024). DOI: 10.1111/coa.14260First-of-it

Updated on: January 21,2025 0

Survival rates for incurable larynx cancer investigated for first time

byNewcastle UniversityKaplan Meier Survival Curves with associated estimated survival rates for entire cohort. Credit:Clinical Otolaryngology(2024). DOI: 10.1111/coa.14260First-of-it

Updated on:January 21,2025 0

Reducing dose of popular blood thinners may limit risk of future bleeding, study finds

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainFor people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospi

Updated on: January 17,2025 0

Reducing dose of popular blood thinners may limit risk of future bleeding, study finds

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainFor people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospi

Updated on:January 17,2025 0